SCHEMBL7990499

SCHEMBL7990499

CCN(CC)C(=O)/C=C(\C)c1ccc(OCc2ccc3ccccc3c2)c(OCC(=O)O)c1

nearest known ligand 0.82

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LTB4R Q15722 20/20 0.82
LTB4R2 Q9NPC1 20/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7990505 1.00 LTB4R (0.82) LTB4RLTB4R2
SCHEMBL7990503 1.00 LTB4R (0.82) LTB4RLTB4R2
SCHEMBL7993662 0.90 LTB4R (1.00) LTB4RLTB4R2
SCHEMBL7993672 0.90 LTB4R (1.00) LTB4RLTB4R2
SCHEMBL7993668 0.90 LTB4R (1.00) LTB4RLTB4R2
SCHEMBL7990613 0.84 LTB4R (0.77) LTB4RLTB4R2
SCHEMBL7990605 0.84 LTB4R (0.77) LTB4RLTB4R2
SCHEMBL7990611 0.84 LTB4R (0.77) LTB4RLTB4R2
SCHEMBL7976187 0.83 LTB4R (0.81) LTB4RLTB4R2
SCHEMBL7976183 0.83 LTB4R (0.81) LTB4RLTB4R2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6291530-B1 Aryl-substituted acrylamides with Leukotriene B4 (LTB-4) receptor antagonist activity NOVARTIS AG (CH) 2001-09-18 US disclosed
EP-0942903-A1 ARYL-SUBSTITUTED ACRYLAMIDES WITH LEUKOTRIENE B4 (LTB-4) RECEPTOR ANTAGONIST ACTIVITY Novartis AG (CH) 1999-09-22 EP disclosed
WO-1998013347-A1 ARYL-SUBSTITUTED ACRYLAMIDES WITH LEUKOTRIENE B4 (LTB-4) RECEPTOR ANTAGONIST ACTIVITY NOVARTIS AG (CH) 1998-04-02 WO disclosed